Literature DB >> 7389238

PCP intoxication in young children and infants.

M J Welch, G A Correa.   

Abstract

Six cases of PCP intoxication in young children age 5 years and younger seen at UCLA Medical Center recently and 10 other cases from the literature are described and their clinical findings summarized. PCP intoxication should be suspected in young children and infants presenting with rapid onset of lethargy or coma, strange behavior, staring spells, ataxia, and nystagmus. Other findings less frequent but still suspect are opisthotonos, hypertension, tachypnea or hyperpnea, miosis, hyperreflexia, hypertonia, and rigidity. Once suspected, the diagnosis is most easily made by finding PCP in the urine. Proper diagnosis of PCP intoxication is important to ensure that rapid, appropriate treatment is given, costly diagnostic workups are avoided, and family evaluations are instituted. One case strongly suggests that intoxication in infants may result from accidental inhalation when near individuals who are smoking PCP.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389238     DOI: 10.1177/000992288001900801

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  8 in total

Review 1.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 2.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

3.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

4.  Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia.

Authors:  Akihito Uezato; Junko Kimura-Sato; Naoki Yamamoto; Yoshimi Iijima; Hiroshi Kunugi; Toru Nishikawa
Journal:  Behav Brain Funct       Date:  2012-01-06       Impact factor: 3.759

5.  Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.

Authors:  F Liu; X Zou; N Sadovova; X Zhang; L Shi; L Guo; F Qian; Z Wen; T A Patterson; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Int J Dev Neurosci       Date:  2010-08-05       Impact factor: 2.457

6.  Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug.

Authors:  Tareg Bey; Anar Patel
Journal:  Cal J Emerg Med       Date:  2007-02

7.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

8.  Reduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophrenia.

Authors:  A Uezato; N Yamamoto; Y Iwayama; S Hiraoka; E Hiraaki; A Umino; E Haramo; M Umino; T Yoshikawa; T Nishikawa
Journal:  Transl Psychiatry       Date:  2015-10-06       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.